Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRATIFY: Thrombolysis Strategies in Pulmonary Embolism
NCT04088292Phase 3Active, not recruiting
- Sponsor
- Rigshospitalet
- Start
- Jun 2019
- Primary completion
- Jun 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in pulmonary embolism (PE), sponsored by Rigshospitalet. Started Jun 2019; status: active, not recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04088292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088292.